Sagent Pharmaceuticals Inc. (Nasdaq: SGNT) will be acquired by Nichi-Iko Pharmaceutical for a premium of approximately $736 million in cash. The stock price leaped $6.15 to close at $21.65.
Sagent Pharmaceuticals to be acquired
July 11, 2016 at 18:36 PM EDT